A Phase 1 Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Glioma Undergoing Surgery
Phase of Trial: Phase I
Latest Information Update: 12 Apr 2016
At a glance
- Drugs Tozuleristide (Primary)
- Indications Glioma; Solid tumours
- Focus Adverse reactions
- Sponsors Blaze Bioscience
- 04 Apr 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Nov 2015 As per Blaze Bioscience media release, interim clinical data from this trial will be presented at the 20th Annual Society for Neuro-Oncology (SNO) Scientific Meeting
- 20 Jul 2015 Planned number of patients changed from 21 to 30 as reported by ClinicalTrials.gov record.